MA56391A - Agonistes du récepteur du peptide de type glucagon 1 - Google Patents

Agonistes du récepteur du peptide de type glucagon 1

Info

Publication number
MA56391A
MA56391A MA056391A MA56391A MA56391A MA 56391 A MA56391 A MA 56391A MA 056391 A MA056391 A MA 056391A MA 56391 A MA56391 A MA 56391A MA 56391 A MA56391 A MA 56391A
Authority
MA
Morocco
Prior art keywords
glucagon
peptide
receptor agonists
agonists
receptor
Prior art date
Application number
MA056391A
Other languages
English (en)
Other versions
MA56391B1 (fr
Inventor
David Andrew Coates
Todd Fields
Joseph Daniel Ho
Fucheng Qu
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority claimed from PCT/US2020/038617 external-priority patent/WO2020263695A1/fr
Publication of MA56391A publication Critical patent/MA56391A/fr
Publication of MA56391B1 publication Critical patent/MA56391B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA56391A 2019-06-28 2020-06-19 Agonistes du récepteur du peptide de type glucagon 1 MA56391B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962868117P 2019-06-28 2019-06-28
PCT/US2020/038617 WO2020263695A1 (fr) 2019-06-28 2020-06-19 Agonistes du récepteur du peptide de type glucagon 1

Publications (2)

Publication Number Publication Date
MA56391A true MA56391A (fr) 2022-05-04
MA56391B1 MA56391B1 (fr) 2023-11-30

Family

ID=80781601

Family Applications (1)

Application Number Title Priority Date Filing Date
MA56391A MA56391B1 (fr) 2019-06-28 2020-06-19 Agonistes du récepteur du peptide de type glucagon 1

Country Status (2)

Country Link
AR (1) AR119173A1 (fr)
MA (1) MA56391B1 (fr)

Also Published As

Publication number Publication date
AR119173A1 (es) 2021-12-01
MA56391B1 (fr) 2023-11-30

Similar Documents

Publication Publication Date Title
IL288479A (en) Glucagon-like peptide 1 receptor agonists
DK3806855T3 (da) GLP-1-receptoragonister og anvendelser deraf
DK3806955T3 (da) GLP-1-receptoragonister og anvendelser deraf
ZA202006115B (en) Phenylpyrrolidinone formyl peptide 2 receptor agonists
DK3810201T5 (da) GIP/GLP1-agonist-sammensætninger
DK4122954T3 (da) Novel GLP-1-analoger
SG11202001637PA (en) Glucagon-like peptide 1 receptor agonists and uses thereof
MA50474A (fr) Co-agonistes à action prolongée des récepteurs du glucagon et du glp-1
EP3359191A4 (fr) Conjugués anticorps-peptides ayant une activité agoniste au niveau des récepteurs au glucagon et au peptide-1 similaire au glucagon
IL291493A (en) dap10/dap12 fusion polypeptides
MA56391A (fr) Agonistes du récepteur du peptide de type glucagon 1
GB201816639D0 (en) GLP-1 Receptor Antagonist
GB201816650D0 (en) GLP-1 Receptor antagonists
GB201910515D0 (en) GLP-1 Receptor antagonists